Pipeline Products
R&D | Pilot Batch | Pivotal Batch | BE Study | Submission | ||||
---|---|---|---|---|---|---|---|---|
Multiple SclerosisOrphan Drug(OEB 4) | ||||||||
Wilson's DiseaseOrphan Drug | ||||||||
FolliculitisHigh Potency (OEB 3) | ||||||||
Pulmonary FibrosisHigh Potency (OEB 3) | ||||||||
Ulcerative ColitisSustained Release | ||||||||
Anti-Rejection for Organ TransplantationSustained Release | ||||||||
MelanomaAnti-Cancer Drug (OEB 5) | ||||||||
MelanomaAnti-Cancer Drug (OEB 2) | ||||||||
Transthyretin Amyloid CardiomyopathyOrphan Drug | ||||||||
Vitamin DeficiencyIn-House API | ||||||||
OsteoporosisHigh Potency (OEB 5) | ||||||||
Anxiety DisorderControlled Substance | ||||||||
Dry Eye DiseasePreservative-free | ||||||||